EBIT: Income before interest and taxes.
TELA Bio, Inc. (TELA) had EBIT of $-10.53M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$19.06M |
|
$-12.27M |
|
$6.44M |
|
$12.62M |
|
$29.59M |
|
$-10.53M |
|
$-1.69M |
|
$-12.21M |
|
$-12.21M |
|
$-12.27M |
|
$-12.27M |
|
$-12.27M |
|
$-12.27M |
|
|
EBIT |
$-10.53M |
$-10.26M |
|
57.26M |
|
57.26M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$64.30M |
|
$2.16M |
|
$5.59M |
|
$69.89M |
|
$17.83M |
|
$55.87M |
|
$57.26M |
|
$75.09M |
|
$-5.20M |
|
$-6.46M |
|
$-5.20M |
|
44.77M |
|
| Cash Flow Statement Financials | |
$-11.17M |
|
$0.19M |
|
$-0.30M |
|
$51.09M |
|
$39.79M |
|
$-11.30M |
|
$0.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.61 |
|
-- |
|
-- |
|
1.10 |
|
-10.74 |
|
66.19% |
|
-55.23% |
|
-55.23% |
|
-- |
|
-64.08% |
|
-64.39% |
|
$-11.29M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
0.53 |
|
1.96 |
|
45.88 |
|
235.97% |
|
189.84% |
|
-17.56% |
|
-24.22% |
|
$-0.12 |
|
$-0.20 |
|
$-0.20 |
|